| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1416101 | EPS8L3 | Lung | Cell line | Calu-3 | Control/Healthy;COVID-19 | GSE151513 | A3SS | G0/G1 | 1 | - |
PV=1 FDR=1 FC=-0.016 |
|
| 1416102 | EPS8L3 | Lung | Cell line | Calu-3 | Control/Healthy;COVID-19 | GSE151513 | A3SS | G0/G1 | 1 | - |
PV=0.031 FDR=0.664 FC=-0.226 |
|
| 1416103 | EPS8L3 | Lung | Cell line | Calu-3 | Control/Healthy;COVID-19 | GSE151513 | A3SS | G0/G1 | 1 | - |
PV=0.247 FDR=1 FC=0.004 |
|
| 1416104 | CACNA2D1 | Lung | Cell line | Calu-3 | Control/Healthy;COVID-19 | GSE151513 | A3SS | G0/G1 | 7 | - |
PV=0.056 FDR=0.831 FC=0.239 |
